Nasmed Ozel Saglik Stock Revenue
| EGEPO Stock | 26.30 0.82 3.02% |
Nasmed Ozel Saglik fundamentals help investors to digest information that contributes to Nasmed Ozel's financial success or failures. It also enables traders to predict the movement of Nasmed Stock. The fundamental analysis module provides a way to measure Nasmed Ozel's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nasmed Ozel stock.
Nasmed |
Nasmed Ozel Saglik Company Revenue Analysis
Nasmed Ozel's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Nasmed Ozel Revenue | 229.67 M |
Most of Nasmed Ozel's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nasmed Ozel Saglik is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Based on the latest financial disclosure, Nasmed Ozel Saglik reported 229.67 M of revenue. This is much higher than that of the sector and significantly higher than that of the Revenue industry. The revenue for all Turkey stocks is notably lower than that of the firm.
Nasmed Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nasmed Ozel's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Nasmed Ozel could also be used in its relative valuation, which is a method of valuing Nasmed Ozel by comparing valuation metrics of similar companies.Nasmed Ozel is currently under evaluation in revenue category among its peers.
Nasmed Fundamentals
| Return On Equity | 0.0238 | |||
| Return On Asset | 0.0221 | |||
| Profit Margin | 0.03 % | |||
| Operating Margin | 0.06 % | |||
| Shares Owned By Insiders | 8.00 % | |||
| Revenue | 229.67 M | |||
| Gross Profit | 40.73 M | |||
| EBITDA | 31.65 M | |||
| Book Value Per Share | 2.45 X | |||
| Earnings Per Share | 0.14 X | |||
| Number Of Employees | 851 |
About Nasmed Ozel Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nasmed Ozel Saglik's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nasmed Ozel using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nasmed Ozel Saglik based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in Nasmed Stock
Nasmed Ozel financial ratios help investors to determine whether Nasmed Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nasmed with respect to the benefits of owning Nasmed Ozel security.